Articles published by Aptevo Therapeutics


Aptevo Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
May 12, 2022
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO

APVO442 Prostate Cancer Data Presented at the American Association for Cancer Research Annual Meeting
April 12, 2022
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO


From Aptevo Therapeutics
Via AccessWire
Tickers
APVO

Aptevo Therapeutics Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update
February 09, 2022
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO


Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication in Peer-Reviewed Journal, "Nature Communication"
December 15, 2021
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO



Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
November 12, 2021
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO

Alligator Bioscience and Aptevo Therapeutics Announce a Poster Presentation of ALG.APV-527 at SITC Annual Meeting 2021
November 11, 2021
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO




Aptevo Therapeutics Announces Publication of a Scientific Article in Peer-Reviewed Journal, Frontiers in Aging
September 28, 2021
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO


Aptevo Therapeutics Reports Second Quarter Financial Results with Business Highlights
August 12, 2021
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO



From Aptevo Therapeutics
Via AccessWire
Tickers
APVO



From Aptevo Therapeutics
Via AccessWire
Tickers
APVO

Aptevo Therapeutics to Present at the American Association for Cancer Research Virtual Annual Meeting
April 09, 2021
From Aptevo Therapeutics
Via AccessWire
Tickers
APVO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.